Chief Commercial Officer · EXOZYMES INC. · Common Stock
Side
SELL
Value
$19K
Shares
3,729
Price
$5.21
Executed
Oct 12, 2026
Disclosed
Oct 26, 2026
Disclosure timeline14 days from execution to publication · legal deadline 2 business days
Oct 12 executedOct 26, 2026 disclosed
EXOZ · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 10 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Perriman Damien Alan filed this Form 4 reporting a open-market sale of EXOZ on Oct 12, 2026. It became public on Oct 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Perriman Damien Alancik:0002096714
Issuer
EXOZYMES INC.cik:0002010788
Revision history · 0
No field has changed since this record was first ingested.
